Literature DB >> 21375368

Differential gene expression in patients with amyotrophic lateral sclerosis.

Alexander Shtilbans1, Soon-Gang Choi, Mary E Fowkes, Greg Khitrov, Mona Shahbazi, Jess Ting, Weijia Zhang, Yezhou Sun, Stuart C Sealfon, Dale J Lange.   

Abstract

Our objective was to analyze gene expression pattern in muscles from patients with amyotrophic lateral sclerosis (ALS) and multifocal motor neuropathy (MMN) compared to controls. Biopsied skeletal muscles from three ALS, three MMN and three control subjects had total RNA extracted and subjected to genome-wide gene expression analysis using Affymetrix GeneChip Exon 1.0 ST array. The most significant expression pattern differences were confirmed with RT-PCR in four additional ALS patients. Results showed that over 3000 genes were identified across the groups using q < 10%. Among 50 genes that were overexpressed only in the ALS group were: leucine-rich repeat kinase-2, follistatin, collagen type XIX alpha-1, ceramide kinase-like, sestrin-3 and CXorf64. No genes were significantly overexpressed in MMN alone. Underexpressed genes only in ALS included actinin α3, fructose-1,6-bisphosphatase-2 and homeobox C10; whereas only in MMN: hemoglobin A1 and CXorf64. Ankyrin repeat domain-1 was overexpressed in both groups. Underexpressed genes in both groups included myosin light chain kinase-2, enolase-3 and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1. Validation analysis using RT-PCR confirmed the data for leucine-rich repeat kinase-2, follistatin, collagen type XIX alpha-1, ceramide kinase-like, sestrin-3 and CXorf64. In conclusion, there is differential tissue-specific gene expression in patients with ALS relative to MMN and controls. Further studies are necessary to evaluate the identified genes in larger patient groups and different tissues.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21375368     DOI: 10.3109/17482968.2011.560946

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  11 in total

1.  BEAT: Bioinformatics Exon Array Tool to store, analyze and visualize Affymetrix GeneChip Human Exon Array data from disease experiments.

Authors:  Arianna Consiglio; Massimo Carella; Giorgio De Caro; Gianfranco Delle Foglie; Candida Giovannelli; Giorgio Grillo; Massimo Ianigro; Flavio Licciulli; Orazio Palumbo; Ada Piepoli; Elena Ranieri; Sabino Liuni
Journal:  BMC Bioinformatics       Date:  2012-03-28       Impact factor: 3.169

Review 2.  The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.

Authors:  Eduardo Gascon; Fen-Biao Gao
Journal:  J Neurogenet       Date:  2014-02-10       Impact factor: 1.250

Review 3.  Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases.

Authors:  Elena Abati; Arianna Manini; Giacomo Pietro Comi; Stefania Corti
Journal:  Cell Mol Life Sci       Date:  2022-06-21       Impact factor: 9.207

4.  Can transcriptomics cut the gordian knot of amyotrophic lateral sclerosis?

Authors:  Alexandre Henriques; Jose-Luis Gonzalez De Aguilar
Journal:  Curr Genomics       Date:  2011-11       Impact factor: 2.236

Review 5.  Investigating cell death mechanisms in amyotrophic lateral sclerosis using transcriptomics.

Authors:  Paul R Heath; Janine Kirby; Pamela J Shaw
Journal:  Front Cell Neurosci       Date:  2013-12-17       Impact factor: 5.505

6.  A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients.

Authors:  Anne-Li Lind; Di Wu; Eva Freyhult; Constantin Bodolea; Titti Ekegren; Anders Larsson; Mats G Gustafsson; Lenka Katila; Jonas Bergquist; Torsten Gordh; Ulf Landegren; Masood Kamali-Moghaddam
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

Review 7.  Gene expression profiling in human neurodegenerative disease.

Authors:  Johnathan Cooper-Knock; Janine Kirby; Laura Ferraiuolo; Paul R Heath; Magnus Rattray; Pamela J Shaw
Journal:  Nat Rev Neurol       Date:  2012-08-14       Impact factor: 42.937

8.  Intricate effects of primary motor neuronopathy on contractile proteins and metabolic muscle enzymes as revealed by label-free mass spectrometry.

Authors:  Ashling Holland; Thomas Schmitt-John; Paul Dowling; Paula Meleady; Michael Henry; Martin Clynes; Kay Ohlendieck
Journal:  Biosci Rep       Date:  2014-07-01       Impact factor: 3.840

9.  Gene profiling of embryonic skeletal muscle lacking type I ryanodine receptor Ca(2+) release channel.

Authors:  Dilyana Filipova; Anna M Walter; John A Gaspar; Anna Brunn; Nina F Linde; Mostafa A Ardestani; Martina Deckert; Jürgen Hescheler; Gabriele Pfitzer; Agapios Sachinidis; Symeon Papadopoulos
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

Review 10.  Type XIX collagen: a promising biomarker from the basement membranes.

Authors:  Ana C Calvo; Laura Moreno; Leticia Moreno; Janne M Toivonen; Raquel Manzano; Nora Molina; Miriam de la Torre; Tresa López; Francisco J Miana-Mena; María J Muñoz; Pilar Zaragoza; Pilar Larrodé; Alberto García-Redondo; Rosario Osta
Journal:  Neural Regen Res       Date:  2020-06       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.